High-Tech Pharma Facility with Patent Portfolio – Acquisition Opportunity
Here are the complete details of the high-tech, export-driven pharma asset, organized in a clear, sequential order:
1. Location & Logistics Hub
- Location: Prime Industrial Zone, Chennai.
- Access: Excellent logistics connectivity featuring a wide 40-ft access road.
- Frontage: Massive 650-ft frontage, highly ideal for large container movement.
2. Property & Infrastructure
- Land Area: 4.5 Acres.
- Built-up Area: 75,000 Sq. Ft. (High-compliance RCC GMP Facility).
3. Technology & Machinery
- Equipment: Equipped with state-of-the-art German-engineered machinery.
- Specialization: Complex tablet formulations with advanced granulation, compression, and coating lines.
4. Manufacturing Capabilities
- Chronic & Metabolic Care: Anti-diabetic (FDC combinations) and Cardiovascular (Amlodipine, Atorvastatin variants).
- Acute & Specialty Generics: Antibiotics (Cephalosporins, Macrolides) and Pain management/NSAIDs.
- Advanced Delivery Systems: Sustained / Modified Release (12–24 hr) and export-grade Nutraceuticals.
5. Licensing, IP & Global Reach
- Patents: Strong portfolio containing 42 Patent Rights for specialized formulations.
- Export Licenses: Active export presence in 21 countries across regulated and semi-regulated markets.
- Regulatory Validity: Valid until 2032.
- Brand Legacy: Over 13 to 15 years of established market reputation backed by a strong international distribution network.
6. Financial & Business Operations
- Annual Turnover: ₹30 Crore.
- Clientele: 32 Pharma Companies relying on the facility for Contract Manufacturing.
- Workforce: 185 Total Employees (60 Technical/Management staff and 125 Operational staff).
7. Valuation & Asking Price
- Market Value (Asset + IP): ₹230 Crore.
- Asking Price: ₹130 Crore (Negotiable).
Yards and Square Feet Real Estate and Strategic Asset Advisory
